Cocrystal Pharma (COCP) Short Interest Ratio & Short Volume → He cracked the code to crypto… (From Weiss Ratings) (Ad) Free COCP Stock Alerts $2.10 +0.23 (+12.30%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Cocrystal Pharma Short Interest DataCurrent Short Volume8,000 sharesPrevious Short Volume1,500 sharesChange Vs. Previous Month+433.33%Dollar Volume Sold Short$12,640.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 30, 2024Outstanding Shares10,170,000 sharesFloat Size7,120,000 sharesShort Percent of Float0.11%Today's Trading Volume69,680 sharesAverage Trading Volume15,113 sharesToday's Volume Vs. Average461% Short Selling Cocrystal Pharma ? Sign up to receive the latest short interest report for Cocrystal Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCOCP Short Interest Over TimeCOCP Days to Cover Over TimeCOCP Percentage of Float Shorted Over Time Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. Cocrystal Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,000 shares $12,640.00 +433.3%0.1%0.6 $1.58 4/15/20241,500 shares $2,100.00 -70.0%0.0%0.1 $1.40 3/31/20245,000 shares $7,000.00 +35.1%0.1%0.4 $1.40 3/15/20243,700 shares $5,624.00 -31.5%0.1%0.3 $1.52 2/29/20245,400 shares $7,722.00 +74.2%0.1%0.4 $1.43 2/15/20243,100 shares $4,774.00 +19.2%0.0%0.2 $1.54 Get the Latest News and Ratings for COCP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cocrystal Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,600 shares $4,134.00 +225.0%0.0%0.1 $1.59 1/15/2024800 shares $1,336.00 -20.0%0.0%0 $1.67 12/31/20231,000 shares $1,722.20 -63.0%0.0%0.1 $1.72 12/15/20232,700 shares $5,103.00 -70.0%0.0%0.1 $1.89 11/30/20239,000 shares $17,100.00 -8.2%0.1%0.4 $1.90 11/15/20239,800 shares $17,738.00 +84.9%0.1%0.4 $1.81 10/31/20235,300 shares $8,798.00 -47.0%0.1%0.2 $1.66 10/15/202310,000 shares $18,400.00 +150.0%0.1%0.3 $1.84 9/30/20234,000 shares $7,480.00 -43.7%0.1%0.1 $1.87 9/15/20237,100 shares $14,058.00 -51.4%0.1%0.2 $1.98 8/31/202314,600 shares $43,800.00 +15.9%0.2%0.5 $3.00 8/15/202312,600 shares $37,170.00 -59.1%0.2%0.4 $2.95 7/31/202330,800 shares $81,928.00 -6.7%0.4%1 $2.66 7/15/202333,000 shares $83,490.00 +28.4%0.5%1.1 $2.53 6/30/202325,700 shares $61,423.00 +21.2%0.4%0.4 $2.39 6/15/202321,200 shares $55,332.00 -4.9%0.3%0.3 $2.61 5/31/202322,300 shares $48,168.00 -34.6%0.4%0.3 $2.16 5/15/202334,100 shares $85,591.00 -13.7%0.5%0.5 $2.51 4/30/202339,500 shares $97,960.00 -45.7%0.8%0.5 $2.48 4/15/202372,800 shares $173,264.00 +1,356.0%1.4%0.9 $2.38 3/31/20235,000 shares $9,950.00 +163.2%0.1%0.1 $1.99 3/15/20231,900 shares $3,553.00 -50.0%0.0%0 $1.87 2/28/20233,800 shares $7,410.00 -2.6%0.1%0.1 $1.95 2/15/20233,900 shares $9,438.00 -89.3%0.1%0.1 $2.42 1/31/202336,600 shares $103,212.00 +500.0%0.5%0.7 $2.82 1/15/20236,100 shares $13,054.00 -63.9%0.1%0.1 $2.14 12/30/202216,900 shares $32,955.00 -15.5%0.2%0.4 $1.95 12/15/202220,000 shares $47,600.00 +769.6%0.3%0.5 $2.38 11/30/20222,300 shares $6,302.00 -81.8%0.0%0.1 $2.74 11/15/202212,600 shares $38,178.00 -83.3%0.2%0.3 $3.03 10/31/202275,400 shares $186,992.00 +199.2%1.1%2 $2.48 10/15/202225,200 shares $59,976.00 +180.0%0.4%0.8 $2.38 9/30/20229,000 shares $31,428.00 -94.6%0.1%0.4 $3.49 9/15/2022167,000 shares $60,120.00 +50.7%1.7%0.8 $0.36How to Play the AI and Crypto Markets in One Swing (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. COCP Short Interest - Frequently Asked Questions What is Cocrystal Pharma's current short interest? Short interest is the volume of Cocrystal Pharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 8,000 shares of COCP short. 0.11% of Cocrystal Pharma's shares are currently sold short. Learn More on Cocrystal Pharma's current short interest. What is a good short interest ratio for Cocrystal Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COCP shares currently have a short interest ratio of 1.0. Learn More on Cocrystal Pharma's short interest ratio. What is a good short interest percentage for Cocrystal Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of Cocrystal Pharma's floating shares are currently sold short. Is Cocrystal Pharma's short interest increasing or decreasing? Cocrystal Pharma saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 8,000 shares, an increase of 433.3% from the previous total of 1,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cocrystal Pharma's float size? Cocrystal Pharma currently has issued a total of 10,170,000 shares. Some of Cocrystal Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cocrystal Pharma currently has a public float of 7,120,000 shares. How does Cocrystal Pharma's short interest compare to its competitors? 0.11% of Cocrystal Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cocrystal Pharma: Indaptus Therapeutics, Inc. (0.44%), Sol-Gel Technologies Ltd. (0.04%), Aytu BioPharma, Inc. (7.15%), Galecto, Inc. (0.42%), KALA BIO, Inc. (0.36%), VBI Vaccines Inc. (1.38%), NeuroBo Pharmaceuticals, Inc. (2.06%), BioVie Inc. (3.18%), GlycoMimetics, Inc. (9.45%), Synlogic, Inc. (0.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cocrystal Pharma stock? Short selling COCP is an investing strategy that aims to generate trading profit from Cocrystal Pharma as its price is falling. COCP shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cocrystal Pharma? A short squeeze for Cocrystal Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COCP, which in turn drives the price of the stock up even further. How often is Cocrystal Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COCP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: INDP Short Interest SLGL Short Interest AYTU Short Interest GLTO Short Interest KALA Short Interest VBIV Short Interest NRBO Short Interest BIVI Short Interest GLYC Short Interest SYBX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COCP) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon to Transform U.S. Economy? Porter & CompanyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing